Skip to main content
. 2024 Oct 31;29(21):5176. doi: 10.3390/molecules29215176

Figure 8.

Figure 8

Quercetin enhances sensitivity to MFA treatment in RT112 (a) and J82 cells (b). Cells were treated with mafosfamide (MFA 2.5 μg/mL), quercetin (Q; 10 μM), or their combination, as indicated. Cell viability was evaluated by crystal violet assay after 48 h. Bar graphs represent the mean of n = 2 experiments performed in triplicate (s.d.). Symbols indicate significance: p < 0.05 (*) with respect to Q and MFA mono-treatments.